CAT: Announces 2018 year end results, outlook for 2019

—

TRVN: Announces receipt of Type A meeting and provides positive update for Oliceridine

—

LODE: Announces Mine Sale,Enables Immediate value, shares soaring In PM

—

AUDC: Reports 4Q and full year Results, Declares semi Annual Dividend of 11 cents

—

BW: Announces turnover of U.K. Renewable Energy Project Featuring Advanced waste combustion Tech.

—

APDN: Signs MOU with Tex-Ray Industrial to introduce CertainT. Authentication Platform to Global Tex. Brands

—

ATOS: President And CEO Dr. Steven C. Quay Issues Annual letter to Shareholders

—

BIOC: Launches Liquid biopsy kits intended to Broaden use of its Proprietary Technology Platform for High Sensitivity Detection of Circulating Tumor DNA

—

AVCO: Announce Discovery and Development of World’s First Saliva-Based Exosomal Biomarker “miR-185” as Dual Diagnostic and Therapeutic Target for Oral Cancer

—

ABBV: Announces U.S. FDA Approval of IMBRUVICA

—

AVGR: Pantheris Featured Live in Case Transmission at Leipzig International Course

—

OGEN: Recieves Further Validation for Lantibiotic Compound OG716

—ic Compound OG716

—